Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
EDIT
Stock Latest News
Company Announcements
Editas Medicine Stockholders Approve Key Amendments
5d ago
8K
EDIT
Premium
The Fly
Prime Medicine price target lowered to $12 from $16 at Chardan
20d ago
EDIT
PRME
Premium
Ratings
Cautious Outlook on Editas Medicine: Hold Rating Amidst Preclinical Progress and Financial Considerations
23d ago
EDIT
Premium
Ratings
Promising Preclinical Data and Market Opportunities Drive Buy Rating for Editas Medicine
23d ago
EDIT
Premium
Company Announcements
Editas Medicine Reports Q1 2025 Progress and Financials
24d ago
EDIT
Premium
The Fly
Editas Medicine reports new in vivo data on HBG1/2 promoter editing in HSCs
25d ago
EDIT
Premium
Company Announcements
Editas Medicine Unveils Promising Gene Editing Data
25d ago
8K
EDIT
Premium
Company Announcements
Editas Medicine Unveils In Vivo Gene Editing Data
26d ago
8K
EDIT
Premium
The Fly
Editas Medicine reports new in vivo proof of concept data for liver target
26d ago
EDIT
Premium
The Fly
Editas Medicine price target lowered to $4 from $8 at Baird
26d ago
EDIT
Premium
Ratings
Editas Medicine: Hold Rating Amid Legal Uncertainty and Financial Concerns
26d ago
EDIT
Premium
Ratings
Buy Rating for Editas Medicine: Promising Advancements in In Vivo Gene Editing
26d ago
EDIT
Premium
The Fly
Editas Medicine reports Q1 EPS (92c), consensus (59c)
26d ago
EDIT
Premium
The Fly
Editas Medicine expects cash to fund operations into Q2 of 2027
26d ago
EDIT
Premium
The Fly
Editas says U.S. Court of Appeals remands CRISPR patent interference decision
26d ago
EDIT
Premium
The Fly
Largest borrow rate increases among liquid names
27d ago
FTI
SAP
Premium
The Fly
Largest borrow rate increases among liquid names
30d ago
DNA
AZUL
Premium
Weekend Updates
Cognex, Editas, Akebia, Tvardi, Chipotle: Trending by Analysts
1M ago
CMG
AKBA
Premium
The Fly
Editas Medicine initiated with a Buy at H.C. Wainwright
1M ago
EDIT
Premium
Pre-Earnings
Is EDIT a Buy, Before Earnings?
1M ago
EDIT
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
DDC
PLX
Premium
Company Announcements
Editas Medicine Announces CFO Transition
3M ago
8K
EDIT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
